CTLp and HTLp frequencies of IUT patients against 1 or more IUT donors
| Recipient . | No. IUTs {IUT tested} . | CTLp/1 × 106 . | HTLp/1 × 106 . | ||
|---|---|---|---|---|---|
| Donor (+FK18) . | 3dp (+FK18) . | Donor . | 3dp . | ||
| 1 | 2 {2} | 49 (14) | 58 (20) | 73 | 31 |
| 2 | 3 {1} | 370 (38) | 162 (28) | 1475 | 171 |
| 3 | 3 {1} | 141 (25) | 138 (15)* | 127 | 194 |
| 3 {2} | 40 (6) | 64 (12) | 180 | 215 | |
| 4 | 2 {2} | 71* | 99* | 175 | 886 |
| 5 | 2 {1} | 417 (20) | 88 (7)* | 969 | 357 |
| 6 | 1 {1} | 32 (2) | 43 (4) | 621 | 499 |
| 7 | 4 {2} | 134 (28) | 140 (19)* | 350 | 110 |
| 8 | 4 {1} | 226 (20) | 82 (11) | 40 | 64 |
| 9 | 1 {1} | 38 (0) | 111 (15) | 566 | 1175 |
| Recipient . | No. IUTs {IUT tested} . | CTLp/1 × 106 . | HTLp/1 × 106 . | ||
|---|---|---|---|---|---|
| Donor (+FK18) . | 3dp (+FK18) . | Donor . | 3dp . | ||
| 1 | 2 {2} | 49 (14) | 58 (20) | 73 | 31 |
| 2 | 3 {1} | 370 (38) | 162 (28) | 1475 | 171 |
| 3 | 3 {1} | 141 (25) | 138 (15)* | 127 | 194 |
| 3 {2} | 40 (6) | 64 (12) | 180 | 215 | |
| 4 | 2 {2} | 71* | 99* | 175 | 886 |
| 5 | 2 {1} | 417 (20) | 88 (7)* | 969 | 357 |
| 6 | 1 {1} | 32 (2) | 43 (4) | 621 | 499 |
| 7 | 4 {2} | 134 (28) | 140 (19)* | 350 | 110 |
| 8 | 4 {1} | 226 (20) | 82 (11) | 40 | 64 |
| 9 | 1 {1} | 38 (0) | 111 (15) | 566 | 1175 |
Precursor frequencies are displayed as number of precursors per 1 × 106 nucleated cells. No IUTs refers to the total number of IUTs; number between brackets ({ }) refers to the specific IUT donor tested. CTLp frequencies determined after addition of anti-CD8 antibody (FK 18) to effector cells are displayed in parentheses.
Frequencies with a goodness of fit > 15. 3dp, third-party controls.